A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain
Public ClinicalTrials.gov record NCT05560646. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2a/b, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multicenter, Clinical Study to Evaluate the Efficacy and Safety of OG-6219 in 3 Dose Levels, in Women 18 to 49 Years of Age With Moderate to Severe Endometriosis-related Pain
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this global Phase 2 study is to determine the efficacy, safety, and tolerability of 3 dose levels of OG-6219 in pre-menopausal women between 18 and 49 years of age (inclusive), who have moderate to severe endometriosis-related pain.
Study identification
- NCT ID
- NCT05560646
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 354 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 49 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 25, 2022 (Actual)
- Primary completion
- May 28, 2025 (Actual)
- Completion
- May 28, 2025 (Actual)
- Last update posted
- May 8, 2026
2022 – 2025
United States locations
- U.S. sites
- 27
- U.S. states
- 17
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Central Research Associates LLC dba Flourish Research | Birmingham | Alabama | 35205 | — |
| UAB Center for Women's Reproductive Health | Birmingham | Alabama | 35233 | — |
| Olympia Clinical Trials | Los Angeles | California | 90036 | — |
| Yale Fertility Center | Orange | Connecticut | 06477 | — |
| Physician Care Clinical Research, LLC | Sarasota | Florida | 34239 | — |
| University of South Florida | Tampa | Florida | 33606 | — |
| MediSense Inc | Atlanta | Georgia | 30363 | — |
| Paramount Research Solutions | College Park | Georgia | 30349 | — |
| Infinite Clinical Trials | Morrow | Georgia | 30260 | — |
| The Advanced Gynecologic Surgery Institute | Park Ridge | Illinois | 60068 | — |
| Ochsner Health Center - Baptist McFarland Medical Plaza | New Orleans | Louisiana | 70115 | — |
| Omni Fertility and Laser Institute | Shreveport | Louisiana | 71118 | — |
| John Hopkins University | Baltimore | Maryland | 21205 | — |
| Bosque Women's Care | Albuquerque | New Mexico | 87109 | — |
| University of Cincinnati | Cincinnati | Ohio | 45267-0502 | — |
| Centricity Research Dublin | Dublin | Ohio | 43016 | — |
| Penn State Health Women's Health Clinic | Hershey | Pennsylvania | 17033 | — |
| Clinical Research of Philadelphia, LLC | Philadelphia | Pennsylvania | 19114 | — |
| Palmetto Clinical Research | Summerville | South Carolina | 29485 | — |
| Chattanooga Medical Research, LLC | Chattanooga | Tennessee | 37404 | — |
| Cedar Health Research, LLC | Euless | Texas | 76040 | — |
| The Women's Hospital of Texas | Houston | Texas | 77024 | — |
| Clinical Trial Network LLC | Houston | Texas | 77074 | — |
| Northeast Clinical Research of San Antonio | San Antonio | Texas | 78233 | — |
| Wasatch Clinical Research | Salt Lake City | Utah | 84107 | — |
| Tidewater Clinical Research | Norfolk | Virginia | 23502 | — |
| Seattle Women's: Health, Research, Gynecology | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 59 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05560646, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 8, 2026 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05560646 live on ClinicalTrials.gov.